Preclinical Evaluation of Bone Marrow Mesenchymal Stem Cells Overexpressing MicroRNA-126 to Treat Critical Limb Ischemia
Pegah Nammian(Shiraz University of Medical Sciences), Vahid Razban(Agri Food and Biosciences Institute), Sajad Daneshi(Shiraz University of Medical Sciences), Kaoru Tabei(Shiraz University of Medical Sciences), Jafar Fallahi(Shiraz University of Medical Sciences), Seyedeh-Leili Asadi-Yousefabad(Shahid Sadoughi University of Medical Sciences and Health Services)
Cited by 0
Related Papers
Decellularized human ovarian scaffold based on a sodium lauryl ester sulfate (SLES)-treated protocol, as a natural three-dimensional scaffold for construction of bioengineered ovaries
|Stem Cell Research & Therapy|2018|133
In Vivo Therapeutic Potential of Mesenchymal Stromal Cells Depends on the Source and the Isolation Procedure
|Stem Cell Reports|2015|120
HIF-1α Overexpression Induces Angiogenesis in Mesenchymal Stem Cells
|BioResearch open access|2012|82
Comparative analysis of mouse bone marrow and adipose tissue mesenchymal stem cells for critical limb ischemia cell therapy
|Stem Cell Research & Therapy|2021|63
Creating cell and animal models of human disease by genome editing using CRISPR/Cas9
|The Journal of Gene Medicine|2019|60